CHICAGO–(BUSINESS WIRE)– #BioTechNews–VectorBuilder, a global leader in gene delivery technologies and CDMO solutions, will participate in the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting, taking place in Denver, Colorado, from May 3 to 7. As AAV-based gene therapies continue to gain traction in ophthalmology, attention is shifting toward the underlying factors that influence consistency, durability, and clinical performance. Variability in vector design and production remains
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
